Pharma

Pure Biologics To Get 32.4 Mln Zloty Subsidy For PB004 Pure Bike Project

  • January 23, 2023 08:27 AM CET | Reuters
 Pure Biologics To Get 32.4 Mln Zloty Subsidy For PB004 Pure Bike Project

Jan 23 (Reuters) - Pure Biologics SA: * SIGNS DEAL WITH MEDICAL RESEARCH AGENCY FOR EXECUTION AND SUBSIDY FOR PB004 PURE BIKE PROJECT * VALUE OF SUBSIDY AT 32.4 MILLION ZLOTYS Source text for Eikon:

Read More...

Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement

Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement

  • January 16, 2023 10:24 AM CET | Reuters

(Adds details, background) Jan 16 (Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday.

Read More...
AbbVie, Eli Lilly exit UK drug pricing agreement

AbbVie, Eli Lilly exit UK drug pricing agreement

  • January 16, 2023 09:58 AM CET | Reuters

(Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday. Companies are increasingly arguing that

Read More...
Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement

Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement

  • January 16, 2023 09:54 AM CET | Reuters

Jan 16 (Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday. Companies are increasingly

Read More...
U.S. Supreme Court to weigh key standard in whistleblower fraud cases

U.S. Supreme Court to weigh key standard in whistleblower fraud cases

  • January 13, 2023 11:51 PM CET | Reuters

By Brendan Pierson Jan 13 (Reuters) - The U.S. Supreme Court on Friday agreed to consider reviving two lawsuits accusing pharmacy operators of overbilling government health insurance programs for

Read More...
FOCUS-Drug companies favor biotech meds over pills, citing new U.S. law

FOCUS-Drug companies favor biotech meds over pills, citing new U.S. law

  • January 13, 2023 01:00 PM CET | Reuters

By Deena Beasley San Francisco, Jan 13 (Reuters) - Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S. legislation gives biologics a

Read More...
AstraZeneca signs COVID treatment deal with China's Genertec Meheco

AstraZeneca signs COVID treatment deal with China's Genertec Meheco

  • January 13, 2023 11:00 AM CET | Reuters

BEIJING (Reuters) - AstraZeneca has signed a cooperation agreement with China's Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday. Genertec Meheco, a unit of Shanghai-listed China

Read More...
White house: Price hike for Moderna's COVID shots hard to justify

White house: Price hike for Moderna's COVID shots hard to justify

  • January 12, 2023 09:58 PM CET | Reuters

WASHINGTON, Jan 12 (Reuters) - The price hike for Moderna Inc COVID-19 shots is hard to justify, White House spokesperson Karine Jean-Pierre said on Thursday. Moderna is considering pricing its

Read More...
KNF Says It Approved Scope Fluidics Prospectus To Move Its Shares To WSE Main Market

KNF Says It Approved Scope Fluidics Prospectus To Move Its Shares To WSE Main Market

  • January 12, 2023 02:25 PM CET | Reuters

Jan 12 (Reuters) - * POLAND'S FIN REGULATOR KNF APPROVES SCOPE FLUIDICS PROSPECTUS TO MOVE ITS SHARES TO WSE MAIN MARKET Source text: https://bit.ly/3k4phf3 Further company coverage: (Reporting by

Read More...
Mainland Chinese head to Hong Kong for mRNA COVID vaccines

Mainland Chinese head to Hong Kong for mRNA COVID vaccines

  • January 12, 2023 02:00 PM CET | Reuters

By Joyce Zhou HONG KONG (Reuters) - Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country

Read More...
MEDIA-EU draws up plans to stockpile scarce medicines - FT

MEDIA-EU draws up plans to stockpile scarce medicines - FT

  • January 12, 2023 06:07 AM CET | Reuters

-- Source link: https://on.ft.com/3GzJAZA -- Note: Reuters has not verified this story and does not vouch for its accuracy

Read More...

Frequently Asked Questions

3232